Table of Content

1 HIV Therapy Drug Market Overview
1.1 Product Overview and Scope of HIV Therapy Drug
1.2 HIV Therapy Drug Segment by Type
1.2.1 Global HIV Therapy Drug Market Value Comparison by Type (2024-2034)
1.2.2 Multi-Type Combined Drugs
1.2.3 Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
1.2.5 Hiv Integrated Enzyme Chain Transfer Inhibitor
1.3 HIV Therapy Drug Segment by Application
1.3.1 Global HIV Therapy Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global HIV Therapy Drug Market Size Estimates and Forecasts
1.4.1 Global HIV Therapy Drug Revenue 2024-2034
1.4.2 Global HIV Therapy Drug Sales 2024-2034
1.4.3 Global HIV Therapy Drug Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 HIV Therapy Drug Market Competition by Manufacturers
2.1 Global HIV Therapy Drug Sales Market Share by Manufacturers (2024-2024)
2.2 Global HIV Therapy Drug Revenue Market Share by Manufacturers (2024-2024)
2.3 Global HIV Therapy Drug Average Price by Manufacturers (2024-2024)
2.4 Global HIV Therapy Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of HIV Therapy Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV Therapy Drug, Product Type & Application
2.7 HIV Therapy Drug Market Competitive Situation and Trends
2.7.1 HIV Therapy Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HIV Therapy Drug Players Market Share by Revenue
2.7.3 Global HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Therapy Drug Retrospective Market Scenario by Region
3.1 Global HIV Therapy Drug Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global HIV Therapy Drug Global HIV Therapy Drug Sales by Region: 2024-2034
3.2.1 Global HIV Therapy Drug Sales by Region: 2024-2024
3.2.2 Global HIV Therapy Drug Sales by Region: 2024-2034
3.3 Global HIV Therapy Drug Global HIV Therapy Drug Revenue by Region: 2024-2034
3.3.1 Global HIV Therapy Drug Revenue by Region: 2024-2024
3.3.2 Global HIV Therapy Drug Revenue by Region: 2024-2034
3.4 North America HIV Therapy Drug Market Facts & Figures by Country
3.4.1 North America HIV Therapy Drug Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America HIV Therapy Drug Sales by Country (2024-2034)
3.4.3 North America HIV Therapy Drug Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV Therapy Drug Market Facts & Figures by Country
3.5.1 Europe HIV Therapy Drug Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe HIV Therapy Drug Sales by Country (2024-2034)
3.5.3 Europe HIV Therapy Drug Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Therapy Drug Market Facts & Figures by Country
3.6.1 Asia Pacific HIV Therapy Drug Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific HIV Therapy Drug Sales by Country (2024-2034)
3.6.3 Asia Pacific HIV Therapy Drug Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV Therapy Drug Market Facts & Figures by Country
3.7.1 Latin America HIV Therapy Drug Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America HIV Therapy Drug Sales by Country (2024-2034)
3.7.3 Latin America HIV Therapy Drug Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV Therapy Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Therapy Drug Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa HIV Therapy Drug Sales by Country (2024-2034)
3.8.3 Middle East and Africa HIV Therapy Drug Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV Therapy Drug Sales by Type (2024-2034)
4.1.1 Global HIV Therapy Drug Sales by Type (2024-2024)
4.1.2 Global HIV Therapy Drug Sales by Type (2024-2034)
4.1.3 Global HIV Therapy Drug Sales Market Share by Type (2024-2034)
4.2 Global HIV Therapy Drug Revenue by Type (2024-2034)
4.2.1 Global HIV Therapy Drug Revenue by Type (2024-2024)
4.2.2 Global HIV Therapy Drug Revenue by Type (2024-2034)
4.2.3 Global HIV Therapy Drug Revenue Market Share by Type (2024-2034)
4.3 Global HIV Therapy Drug Price by Type (2024-2034)
5 Segment by Application
5.1 Global HIV Therapy Drug Sales by Application (2024-2034)
5.1.1 Global HIV Therapy Drug Sales by Application (2024-2024)
5.1.2 Global HIV Therapy Drug Sales by Application (2024-2034)
5.1.3 Global HIV Therapy Drug Sales Market Share by Application (2024-2034)
5.2 Global HIV Therapy Drug Revenue by Application (2024-2034)
5.2.1 Global HIV Therapy Drug Revenue by Application (2024-2024)
5.2.2 Global HIV Therapy Drug Revenue by Application (2024-2034)
5.2.3 Global HIV Therapy Drug Revenue Market Share by Application (2024-2034)
5.3 Global HIV Therapy Drug Price by Application (2024-2034)
6 Key Companies Profiled
6.1 ViiV Healthcare
6.1.1 ViiV Healthcare Corporation Information
6.1.2 ViiV Healthcare Description and Business Overview
6.1.3 ViiV Healthcare HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.1.4 ViiV Healthcare HIV Therapy Drug Product Portfolio
6.1.5 ViiV Healthcare Recent Developments/Updates
6.2 Gilead Sciences, Inc
6.2.1 Gilead Sciences, Inc Corporation Information
6.2.2 Gilead Sciences, Inc Description and Business Overview
6.2.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Gilead Sciences, Inc HIV Therapy Drug Product Portfolio
6.2.5 Gilead Sciences, Inc Recent Developments/Updates
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Corporation Information
6.3.2 AbbVie Inc. Description and Business Overview
6.3.3 AbbVie Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.3.4 AbbVie Inc. HIV Therapy Drug Product Portfolio
6.3.5 AbbVie Inc. Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Corporation Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Merck & Co HIV Therapy Drug Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.5.4 GSK HIV Therapy Drug Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Corporation Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Theratechnologies Inc.
6.6.1 Theratechnologies Inc. Corporation Information
6.6.2 Theratechnologies Inc. Description and Business Overview
6.6.3 Theratechnologies Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Theratechnologies Inc. HIV Therapy Drug Product Portfolio
6.7.5 Theratechnologies Inc. Recent Developments/Updates
6.8 Roche Holding AG
6.8.1 Roche Holding AG Corporation Information
6.8.2 Roche Holding AG Description and Business Overview
6.8.3 Roche Holding AG HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Roche Holding AG HIV Therapy Drug Product Portfolio
6.8.5 Roche Holding AG Recent Developments/Updates
6.9 Teva Pharmaceuticals
6.9.1 Teva Pharmaceuticals Corporation Information
6.9.2 Teva Pharmaceuticals Description and Business Overview
6.9.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Teva Pharmaceuticals HIV Therapy Drug Product Portfolio
6.9.5 Teva Pharmaceuticals Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Pfizer HIV Therapy Drug Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Frontier Biotechnologies
6.11.1 Frontier Biotechnologies Corporation Information
6.11.2 Frontier Biotechnologies HIV Therapy Drug Description and Business Overview
6.11.3 Frontier Biotechnologies HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Frontier Biotechnologies HIV Therapy Drug Product Portfolio
6.11.5 Frontier Biotechnologies Recent Developments/Updates
6.12 Shionogi
6.12.1 Shionogi Corporation Information
6.12.2 Shionogi HIV Therapy Drug Description and Business Overview
6.12.3 Shionogi HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Shionogi HIV Therapy Drug Product Portfolio
6.12.5 Shionogi Recent Developments/Updates
6.13 Janssen Pharmaceuticals, Inc.
6.13.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.13.2 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Description and Business Overview
6.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio
6.13.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.14 Mylan Pharmaceuticals Inc.
6.14.1 Mylan Pharmaceuticals Inc. Corporation Information
6.14.2 Mylan Pharmaceuticals Inc. HIV Therapy Drug Description and Business Overview
6.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio
6.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
6.15 Genentech, Inc.
6.15.1 Genentech, Inc. Corporation Information
6.15.2 Genentech, Inc. HIV Therapy Drug Description and Business Overview
6.15.3 Genentech, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Genentech, Inc. HIV Therapy Drug Product Portfolio
6.15.5 Genentech, Inc. Recent Developments/Updates
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Corporation Information
6.16.2 Boehringer Ingelheim HIV Therapy Drug Description and Business Overview
6.16.3 Boehringer Ingelheim HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Boehringer Ingelheim HIV Therapy Drug Product Portfolio
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Corporation Information
6.17.2 Cipla HIV Therapy Drug Description and Business Overview
6.17.3 Cipla HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Cipla HIV Therapy Drug Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 MSD
6.18.1 MSD Corporation Information
6.18.2 MSD HIV Therapy Drug Description and Business Overview
6.18.3 MSD HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.18.4 MSD HIV Therapy Drug Product Portfolio
6.18.5 MSD Recent Developments/Updates
6.19 Abbott
6.19.1 Abbott Corporation Information
6.19.2 Abbott HIV Therapy Drug Description and Business Overview
6.19.3 Abbott HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Abbott HIV Therapy Drug Product Portfolio
6.19.5 Abbott Recent Developments/Updates
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Corporation Information
6.20.2 Johnson & Johnson HIV Therapy Drug Description and Business Overview
6.20.3 Johnson & Johnson HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Johnson & Johnson HIV Therapy Drug Product Portfolio
6.20.5 Johnson & Johnson Recent Developments/Updates
6.21 Biocon Limited
6.21.1 Biocon Limited Corporation Information
6.21.2 Biocon Limited HIV Therapy Drug Description and Business Overview
6.21.3 Biocon Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.21.4 Biocon Limited HIV Therapy Drug Product Portfolio
6.21.5 Biocon Limited Recent Developments/Updates
6.22 Affine Formulations Limited
6.22.1 Affine Formulations Limited Corporation Information
6.22.2 Affine Formulations Limited HIV Therapy Drug Description and Business Overview
6.22.3 Affine Formulations Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.22.4 Affine Formulations Limited HIV Therapy Drug Product Portfolio
6.22.5 Affine Formulations Limited Recent Developments/Updates
6.23 IPCA Laboratories
6.23.1 IPCA Laboratories Corporation Information
6.23.2 IPCA Laboratories HIV Therapy Drug Description and Business Overview
6.23.3 IPCA Laboratories HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.23.4 IPCA Laboratories HIV Therapy Drug Product Portfolio
6.23.5 IPCA Laboratories Recent Developments/Updates
6.24 Natco Pharma
6.24.1 Natco Pharma Corporation Information
6.24.2 Natco Pharma HIV Therapy Drug Description and Business Overview
6.24.3 Natco Pharma HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.24.4 Natco Pharma HIV Therapy Drug Product Portfolio
6.24.5 Natco Pharma Recent Developments/Updates
6.25 Beacon Pharmaceuticals
6.25.1 Beacon Pharmaceuticals Corporation Information
6.25.2 Beacon Pharmaceuticals HIV Therapy Drug Description and Business Overview
6.25.3 Beacon Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.25.4 Beacon Pharmaceuticals HIV Therapy Drug Product Portfolio
6.25.5 Beacon Pharmaceuticals Recent Developments/Updates
6.26 Julphar Bangladesh
6.26.1 Julphar Bangladesh Corporation Information
6.26.2 Julphar Bangladesh HIV Therapy Drug Description and Business Overview
6.26.3 Julphar Bangladesh HIV Therapy Drug Sales, Revenue and Gross Margin (2024-2024)
6.26.4 Julphar Bangladesh HIV Therapy Drug Product Portfolio
6.26.5 Julphar Bangladesh Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Therapy Drug Industry Chain Analysis
7.2 HIV Therapy Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Therapy Drug Production Mode & Process
7.4 HIV Therapy Drug Sales and Marketing
7.4.1 HIV Therapy Drug Sales Channels
7.4.2 HIV Therapy Drug Distributors
7.5 HIV Therapy Drug Customers
8 HIV Therapy Drug Market Dynamics
8.1 HIV Therapy Drug Industry Trends
8.2 HIV Therapy Drug Market Drivers
8.3 HIV Therapy Drug Market Challenges
8.4 HIV Therapy Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global HIV Therapy Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global HIV Therapy Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global HIV Therapy Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global HIV Therapy Drug Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global HIV Therapy Drug Sales Market Share by Manufacturers (2024-2024)
Table 6. Global HIV Therapy Drug Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global HIV Therapy Drug Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market HIV Therapy Drug Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of HIV Therapy Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of HIV Therapy Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HIV Therapy Drug, Product Type & Application
Table 12. Global Key Manufacturers of HIV Therapy Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HIV Therapy Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global HIV Therapy Drug Sales by Region (2024-2024) & (K Units)
Table 18. Global HIV Therapy Drug Sales Market Share by Region (2024-2024)
Table 19. Global HIV Therapy Drug Sales by Region (2024-2034) & (K Units)
Table 20. Global HIV Therapy Drug Sales Market Share by Region (2024-2034)
Table 21. Global HIV Therapy Drug Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global HIV Therapy Drug Revenue Market Share by Region (2024-2024)
Table 23. Global HIV Therapy Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global HIV Therapy Drug Revenue Market Share by Region (2024-2034)
Table 25. North America HIV Therapy Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America HIV Therapy Drug Sales by Country (2024-2024) & (K Units)
Table 27. North America HIV Therapy Drug Sales by Country (2024-2034) & (K Units)
Table 28. North America HIV Therapy Drug Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America HIV Therapy Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe HIV Therapy Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe HIV Therapy Drug Sales by Country (2024-2024) & (K Units)
Table 32. Europe HIV Therapy Drug Sales by Country (2024-2034) & (K Units)
Table 33. Europe HIV Therapy Drug Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe HIV Therapy Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific HIV Therapy Drug Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific HIV Therapy Drug Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific HIV Therapy Drug Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific HIV Therapy Drug Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific HIV Therapy Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America HIV Therapy Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America HIV Therapy Drug Sales by Country (2024-2024) & (K Units)
Table 42. Latin America HIV Therapy Drug Sales by Country (2024-2034) & (K Units)
Table 43. Latin America HIV Therapy Drug Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America HIV Therapy Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa HIV Therapy Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa HIV Therapy Drug Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa HIV Therapy Drug Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa HIV Therapy Drug Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa HIV Therapy Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global HIV Therapy Drug Sales (K Units) by Type (2024-2024)
Table 51. Global HIV Therapy Drug Sales (K Units) by Type (2024-2034)
Table 52. Global HIV Therapy Drug Sales Market Share by Type (2024-2024)
Table 53. Global HIV Therapy Drug Sales Market Share by Type (2024-2034)
Table 54. Global HIV Therapy Drug Revenue (US$ Million) by Type (2024-2024)
Table 55. Global HIV Therapy Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global HIV Therapy Drug Revenue Market Share by Type (2024-2024)
Table 57. Global HIV Therapy Drug Revenue Market Share by Type (2024-2034)
Table 58. Global HIV Therapy Drug Price (US$/Unit) by Type (2024-2024)
Table 59. Global HIV Therapy Drug Price (US$/Unit) by Type (2024-2034)
Table 60. Global HIV Therapy Drug Sales (K Units) by Application (2024-2024)
Table 61. Global HIV Therapy Drug Sales (K Units) by Application (2024-2034)
Table 62. Global HIV Therapy Drug Sales Market Share by Application (2024-2024)
Table 63. Global HIV Therapy Drug Sales Market Share by Application (2024-2034)
Table 64. Global HIV Therapy Drug Revenue (US$ Million) by Application (2024-2024)
Table 65. Global HIV Therapy Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global HIV Therapy Drug Revenue Market Share by Application (2024-2024)
Table 67. Global HIV Therapy Drug Revenue Market Share by Application (2024-2034)
Table 68. Global HIV Therapy Drug Price (US$/Unit) by Application (2024-2024)
Table 69. Global HIV Therapy Drug Price (US$/Unit) by Application (2024-2034)
Table 70. ViiV Healthcare Corporation Information
Table 71. ViiV Healthcare Description and Business Overview
Table 72. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. ViiV Healthcare HIV Therapy Drug Product
Table 74. ViiV Healthcare Recent Developments/Updates
Table 75. Gilead Sciences, Inc Corporation Information
Table 76. Gilead Sciences, Inc Description and Business Overview
Table 77. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Gilead Sciences, Inc HIV Therapy Drug Product
Table 79. Gilead Sciences, Inc Recent Developments/Updates
Table 80. AbbVie Inc. Corporation Information
Table 81. AbbVie Inc. Description and Business Overview
Table 82. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. AbbVie Inc. HIV Therapy Drug Product
Table 84. AbbVie Inc. Recent Developments/Updates
Table 85. Merck & Co Corporation Information
Table 86. Merck & Co Description and Business Overview
Table 87. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Merck & Co HIV Therapy Drug Product
Table 89. Merck & Co Recent Developments/Updates
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. GSK HIV Therapy Drug Product
Table 94. GSK Recent Developments/Updates
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Bristol-Myers Squibb Company HIV Therapy Drug Product
Table 99. Bristol-Myers Squibb Company Recent Developments/Updates
Table 100. Theratechnologies Inc. Corporation Information
Table 101. Theratechnologies Inc. Description and Business Overview
Table 102. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Theratechnologies Inc. HIV Therapy Drug Product
Table 104. Theratechnologies Inc. Recent Developments/Updates
Table 105. Roche Holding AG Corporation Information
Table 106. Roche Holding AG Description and Business Overview
Table 107. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Roche Holding AG HIV Therapy Drug Product
Table 109. Roche Holding AG Recent Developments/Updates
Table 110. Teva Pharmaceuticals Corporation Information
Table 111. Teva Pharmaceuticals Description and Business Overview
Table 112. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Teva Pharmaceuticals HIV Therapy Drug Product
Table 114. Teva Pharmaceuticals Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Pfizer HIV Therapy Drug Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Frontier Biotechnologies Corporation Information
Table 121. Frontier Biotechnologies Description and Business Overview
Table 122. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Frontier Biotechnologies HIV Therapy Drug Product
Table 124. Frontier Biotechnologies Recent Developments/Updates
Table 125. Shionogi Corporation Information
Table 126. Shionogi Description and Business Overview
Table 127. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Shionogi HIV Therapy Drug Product
Table 129. Shionogi Recent Developments/Updates
Table 130. Janssen Pharmaceuticals, Inc. Corporation Information
Table 131. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 132. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product
Table 134. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 135. Mylan Pharmaceuticals Inc. Corporation Information
Table 136. Mylan Pharmaceuticals Inc. Description and Business Overview
Table 137. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product
Table 139. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 140. Genentech, Inc. Corporation Information
Table 141. Genentech, Inc. Description and Business Overview
Table 142. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Genentech, Inc. HIV Therapy Drug Product
Table 144. Genentech, Inc. Recent Developments/Updates
Table 145. Boehringer Ingelheim Corporation Information
Table 146. Boehringer Ingelheim Description and Business Overview
Table 147. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Boehringer Ingelheim HIV Therapy Drug Product
Table 149. Boehringer Ingelheim Recent Developments/Updates
Table 150. Cipla Corporation Information
Table 151. Cipla Description and Business Overview
Table 152. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Cipla HIV Therapy Drug Product
Table 154. Cipla Recent Developments/Updates
Table 155. MSD Corporation Information
Table 156. MSD Description and Business Overview
Table 157. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. MSD HIV Therapy Drug Product
Table 159. MSD Recent Developments/Updates
Table 160. Abbott Corporation Information
Table 161. Abbott Description and Business Overview
Table 162. Abbott HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Abbott HIV Therapy Drug Product
Table 164. Abbott Recent Developments/Updates
Table 165. Johnson & Johnson Corporation Information
Table 166. Johnson & Johnson Description and Business Overview
Table 167. Johnson & Johnson HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Johnson & Johnson HIV Therapy Drug Product
Table 169. Johnson & Johnson Recent Developments/Updates
Table 170. Biocon Limited Corporation Information
Table 171. Biocon Limited Description and Business Overview
Table 172. Biocon Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. Biocon Limited HIV Therapy Drug Product
Table 174. Biocon Limited Recent Developments/Updates
Table 175. Affine Formulations Limited Corporation Information
Table 176. Affine Formulations Limited Description and Business Overview
Table 177. Affine Formulations Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Affine Formulations Limited HIV Therapy Drug Product
Table 179. Affine Formulations Limited Recent Developments/Updates
Table 180. IPCA Laboratories Corporation Information
Table 181. IPCA Laboratories Description and Business Overview
Table 182. IPCA Laboratories HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. IPCA Laboratories HIV Therapy Drug Product
Table 184. IPCA Laboratories Recent Developments/Updates
Table 185. Natco Pharma Corporation Information
Table 186. Natco Pharma Description and Business Overview
Table 187. Natco Pharma HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. Natco Pharma HIV Therapy Drug Product
Table 189. Natco Pharma Recent Developments/Updates
Table 190. Beacon Pharmaceuticals Corporation Information
Table 191. Beacon Pharmaceuticals Description and Business Overview
Table 192. Beacon Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 193. Beacon Pharmaceuticals HIV Therapy Drug Product
Table 194. Beacon Pharmaceuticals Recent Developments/Updates
Table 195. Julphar Bangladesh Corporation Information
Table 196. Julphar Bangladesh Description and Business Overview
Table 197. Julphar Bangladesh HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 198. Julphar Bangladesh HIV Therapy Drug Product
Table 199. Julphar Bangladesh Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. HIV Therapy Drug Distributors List
Table 203. HIV Therapy Drug Customers List
Table 204. HIV Therapy Drug Market Trends
Table 205. HIV Therapy Drug Market Drivers
Table 206. HIV Therapy Drug Market Challenges
Table 207. HIV Therapy Drug Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of HIV Therapy Drug
Figure 2. Global HIV Therapy Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global HIV Therapy Drug Market Share by Type in 2022 & 2034
Figure 4. Multi-Type Combined Drugs Product Picture
Figure 5. Nucleoside Reverse Transcription Enzyme Inhibitors Product Picture
Figure 6. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Product Picture
Figure 7. Hiv Integrated Enzyme Chain Transfer Inhibitor Product Picture
Figure 8. Global HIV Therapy Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global HIV Therapy Drug Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Pharmacy
Figure 13. Global HIV Therapy Drug Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global HIV Therapy Drug Market Size (2024-2034) & (US$ Million)
Figure 15. Global HIV Therapy Drug Sales (2024-2034) & (K Units)
Figure 16. Global HIV Therapy Drug Average Price (US$/Unit) & (2024-2034)
Figure 17. HIV Therapy Drug Report Years Considered
Figure 18. HIV Therapy Drug Sales Share by Manufacturers in 2022
Figure 19. Global HIV Therapy Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest HIV Therapy Drug Players: Market Share by Revenue in 2022
Figure 21. HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 22. Global HIV Therapy Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 23. North America HIV Therapy Drug Sales Market Share by Country (2024-2034)
Figure 24. North America HIV Therapy Drug Revenue Market Share by Country (2024-2034)
Figure 25. United States HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Canada HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Europe HIV Therapy Drug Sales Market Share by Country (2024-2034)
Figure 28. Europe HIV Therapy Drug Revenue Market Share by Country (2024-2034)
Figure 29. Germany HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. France HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. U.K. HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Italy HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Russia HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Asia Pacific HIV Therapy Drug Sales Market Share by Region (2024-2034)
Figure 35. Asia Pacific HIV Therapy Drug Revenue Market Share by Region (2024-2034)
Figure 36. China HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Japan HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. South Korea HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. India HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Australia HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. China Taiwan HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Southeast Asia HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Latin America HIV Therapy Drug Sales Market Share by Country (2024-2034)
Figure 44. Latin America HIV Therapy Drug Revenue Market Share by Country (2024-2034)
Figure 45. Mexico HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Brazil HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Argentina HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Colombia HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa HIV Therapy Drug Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa HIV Therapy Drug Revenue Market Share by Country (2024-2034)
Figure 51. Turkey HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE HIV Therapy Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of HIV Therapy Drug by Type (2024-2034)
Figure 55. Global Revenue Market Share of HIV Therapy Drug by Type (2024-2034)
Figure 56. Global HIV Therapy Drug Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of HIV Therapy Drug by Application (2024-2034)
Figure 58. Global Revenue Market Share of HIV Therapy Drug by Application (2024-2034)
Figure 59. Global HIV Therapy Drug Price (US$/Unit) by Application (2024-2034)
Figure 60. HIV Therapy Drug Value Chain
Figure 61. HIV Therapy Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed